None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children age > 1year to Children receiving one injection at a time Children whose families give consent Children receiving vaccines only through intramuscular route
Exclusion criteria
Exclusion criteria: Children receiving DPT containing vaccines Children receiving vaccines via subcutaneous or intradermal route of administration Presence of any disease which causes chronic pain Children with neurodevelopmental disorders History of fainting during injection Presence of any skin disease Families those who didn’t give consent Infections at the site of injection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of lignocaine cold spray and shotblocker in reducing the intramuscular (IM) injection-related pain in children.Timepoint: Pain scale assessed at 0 min and at 5 minutes of administration of injection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cost effective Easy to use Side effectsTimepoint: Child observed for 30 minutes after IM injection for any adverse effects | — |
Countries
India
Contacts
Chettinad hospital and research institute